The three groups of treatment were similar regarding other AEs such as proteinuria of grade 3 or greater, GIP or fistula, neutropenia of grade 4 and febrile neutropenia, venous or arterial thrombosis, and wound disruption. This evidence concerns the gene GIP and neutropenia.